Aditxt (NASDAQ:ADTX) stock is in the spotlight after the company implemented a reverse stock split Tuesday. Down 16% as of this writing, today’s movement in ADTX stock comes after shares soared more than 100% yesterday.
Based in Virginia, Aditxt develops products that enhance people’s immune systems. Its offerings include AditxtScore, which evaluates immune systems, and Apoptotic DNA Immunotherapy, a technology that seeks to provide the same benefits of traditional immune suppression drugs while significantly reducing the intensity of their negative side effects.
Here’s what investors should know about ADTX stock moving forward.
This post originally appeared at InvestorPlace.